Antitrust Antitrust

French pharma antitrust fines draw on Italian experience, De Silva says

By Arezki Yaïche
  • 09 Sep 2020 09:32
  • 09 Oct 2020 09:53

Today’s record-breaking French fine against three drugmakers drew on the experience of a related 2014 Italian fine and may face an equally arduous legal battle, the head of the French competition authority has said.

Roche, Novartis and Genentech can be expected to appeal the fines totaling 444 million euros ($523 million)

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News